Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families

Clinical Cancer Research

Volumn 5, Issue 6, 1999, Pages 1275-1279

  Matikainen, Mika P ^a   Schleutker, Johanna ^a   Mörsky, Pertti ^b   Kallioniemi, Olli P ^a,c   Tammela, Teuvo L J ^b  

^a UNIVERSITY OF TAMPERE   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; DIAGNOSTIC VALUE; FAMILIAL CANCER; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

ADENOCARCINOMA; AGE OF ONSET; AGED; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0032979211     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Finnish Cancer Registry. Cancer Incidence in Finland 1995: Cancer Statistics of the National Research and Development Centre for Welfare and Health. Cancer Society of Finland, Publ. No. 58. Helsinki, Finland, 1997.
2. Carter, B. S., Beaty, T. H., Steinberg, G. D., Childs, B., and Walsh, P. C. Mendelian inheritance of familial prostate cancer. Proc. Natl. Acad. Sci. USA, 89: 3367-3371, 1992.
3. Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B., and Walsh, P. C. Hereditary prostate cancer: epidemiologic and clinical features. J. Urol., 150: 797-802, 1993.
4. Goldgar, D. E., Easton, D. F., Cannon-Albright, L. A., and Skolnick, M. H. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J. Natl. Cancer Inst. (Bethesda), 86: 1600-1607, 1994.
5. Grönberg, H., Damber, L., and Damber, J. E. Familial prostate cancer in Sweden: a nationwide register cohort study. Cancer (Phila.), 77: 138-143, 1996.
6. Smith, J. R., Freije, D., Carpten, J. D., Grönberg, H., Xu, J., Isaacs, S. D., Brownstein, M. J., Bova, G. S., Guo, H., Bujnovszky, P., Nusskern, D. R., Damberg, J-E., Bergh, A., Emanuelsson, M., Kallioniemi, O-P., Walker-Daniels, J., Bailey-Wilson, J. E., Beaty, T. H., Meyers, D. A., Walsh, P. C., Collins, F. S., Trent, J. M., and Isaacs, W. B. A genome wide search reveals a major susceptibility locus for prostate cancer on chromosome 1. Science (Washington DC), 274: 1371-1374, 1996.
7. Grönberg, H., Isaacs, S. D., Smith, J. R., Carpten J. D., Xu, J., Bova, G. S., Freije, D., Meyers, D. A., Collins, F. S., Trent, J. M., Walsh, P. C., and Isaacs, W. B. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. J. Am. Med. Assoc., 278: 1251-1255, 1997.
8. Berthon, P., Valeri, A., Cohen-Akenine, A., Drelon, E., Paiss, T., Wöhr, G., Latil, A., Millasseau, P., Mellah, I., Cohen N., Blanche, H., Bellane-Chantelot, C., Demenais, F., Teillac, P., Le Duc, A., de Petriconi, R., Hautmann, R., Chumakov, I., Bachner, L., Maitland, N. J., Lidereau, R., Vogel, W., Fournier, G., Mangin, P., Cohen, D., and Cussenot, O. Predisposing gene for early-onset prostate cancer, localized on chromosome 1q42.2-43. Am. J. Hum. Genet., 62: 1416-1424, 1998.
9. Xu, J., Meyers, D., Freije, D., Isaacs, S., Wiley, K., Nusskern, D., Ewing, C., Wilkens, E., Bujnovszky, P., Bova, G. S., Walsh, P., Isaacs, W., Schleutker, J., Matikainen, M., Tammela, T., Visakorpi, T., Kallioniemi, O-P., Berry, R., Schaid, D., French, A., McDonnell, S., Schroeder, J., Blute, M., Thibodeau, S., Grönberg, H., Emanuelsson, M., Damber, J-E., Bergh, A., Jonsson, B-A., Smith, J., Bailey-Wilson, J., Carpten, J., Stephan, D., Gillanders, E., Amundson, I., Kainu, T., Freas-Lutz, D., Baffoe-Bonnie, A., Van Aucken, A., Sood, R., Collins, F., Brownstein, M., and Trent, J. Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat. Genet., 20: 175-179, 1998.
10. Cooney, K. A., McCarthy, J. D., Lange, E., Huang, L., Miesfeldt, S., Montie, J. E., Oesterling, J. E., Sandler, H. M., and Lange, K. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J. Natl. Cancer Inst. (Bethesda), 89: 955-958, 1997.
11. Hsieh, C. L., Oakley-Girvan, I., Gallagher, R. P., Wu, A. H., Kolonel, L. N., The, C. Z., Halpern, J., West, D. W., Paffenbarger, R. S., Jr., and Whittemore, A. S. Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J. Natl. Cancer Inst. (Bethesda), 89: 1893-1894, 1997.
12. Giovannucci, E., Stampfer, M. J., Krithivas, K., Brown, M., Brufsky, A., Talcott, J., Hennekens, C. H., and Kantoff, P. W. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl. Acad. Sci. USA, 94: 3320-3323, 1997.
13. Reichardt, J. K. V., Makridakis, N., Henderson, B. E., Yu, M. C., Pike, M. C., and Ross, R. K. Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk. Cancer Res., 55: 3973-3975, 1995.
14. Taylor, J. A., Hirvonen, A., Watson, M., Pittman, G., Mohler, J. L., and Bell, D. A. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res., 56: 4108-4110, 1996.
15. Bratt, O., Kristofferson, U., Lundgren, R., and Olsson, H. Sons of men with prostate cancer: their attitudes regarding possible inheritance of prostate cancer, screening and genetic testing. Urology, 50: 360-365, 1997.
16. Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J., Petros, J. A., and Andriole, G. L. Measurement of prostate specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med., 342: 1156-1161, 1991.
17. Labrie, F., Dupont, A., Suburu, R., Cusan, L., Tremblay, M., Comez, J-L., and Emond, J. Serum prostate specific antigen as prescreening test for prostate cancer. J. Urol., 147: 846-852, 1992.
18. Auvinen, A., Tammela, T., Stenman, U.-H., Uusi-Erkkilä, I., Leinonen, J., Schröder, F. H., and Hakama, M. Screening for prostate cancer using serum prostate specific antigen: a randomised, population-based pilot study in Finland. Br. J. Cancer, 74: 568-572, 1996.
19. McWhorter, W. P., Hernandez, A. D., Meikle, A. W., Terreros, D. A., Smith, J. A., Jr., Skolnick, M. H., Cannon-Albright, L. A., and Eyre, H. J. A screening study of prostate cancer in high risk families. J. Urol., 148: 826-828, 1992.
20. Narod, S. A., Dupont, A., Cusan, L., Diamond, P., Gomez, J-L., Suburu, R., and Labrie, F. The impact of family history on early detection of prostate cancer. Nat. Med., 1: 99-101, 1995.
21. Hugonsson, J., Aus, G., Bergdahl, S., Frösing, R., Lodding, P., Fernlund, P., and Lilja, H. The value of the ratio of free/total PSA in screening for prostate cancer, preliminary data from Gothenburg screening study for prostate cancer. J. Urol. Suppl., 157: 118, 1997.
22. Bangma, C. H., Rietberger, J. B. W., and Schröder, F. H. Prostate-specific antigen as a screening test. The Netherlands experience. Urol. Clin. North Am., 24: 307-314, 1997.
23. Standaert, B., and Denis, L. The European randomized study of screening for prostate cancer: an update. Cancer (Phila.), 80: 1830-1834, 1997.
24. Catalona, W. J., Smith, D. S., Ratliff, T. L., and Basler, J. W. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J. Am. Med. Assoc., 270: 948-954, 1993.
25. Mettlin, C., Murphy, G. P., Babaian, R. J., Chesley, A., Kane, R. A., Littrup, P. J., Mostofi, F. K., Ray, P. S., Shanberg, A. M., and Toi, A. The results of a five-year early prostate cancer detection intervention. Cancer (Phila.), 77: 150-159, 1996.
26. Woolf, C. M. An investigation of the familial aspects of carcinoma of the prostate. Cancer (Phila.), 13: 739-744, 1960.
27. Cannon, L., Bishop, D. T., Skolnick, M., Hunt, S., Lyon, J. L., and Smart, C. R. Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv., 1: 47-69, 1982.
28. Meikle, A. W., Smith, J. A., and West, D. W. Familial factors affecting prostatic cancer risk and plasma sex-steroid levels. Prostate, 6: 121-128, 1985.
29. Monroe, K. R., Yu, M. C., Kolonel, L. N., Coetzee, G. A., Wilkens, L. R., Ross, R. K., and Henderson, B. E. Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat. Med., 1: 827-829, 1995.
30. Lesko, S. M., Rosenberg L., and Shapiro, S. Family history and prostate cancer risk. Am. J. Epidemiol., 144: 1041-1047, 1996.
31. Neuhausen, S. L., Skolnick, M. H., and Cannon-Albright, L. Familial prostate cancer studies in Utah. Br. J. Urol., 79 (Suppl. 1): 15-20, 1997.
32. Stenman, U-H., Hakama, M., Knekt, P., Aromaa, A., Teppo, L., and Leinonen, J. Serum concentrations of prostate specific antigen and its complex with al-antichymotrypsin before diagnosis of prostate cancer. Lancet, 344: 1594-1598, 1994.
33. Keetch, D. W., Catalona, W. J., and Smith, D. S. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J. Urol., 151: 1571-1574, 1994.
34. Walsh, P. C., and Partin, A. W. Family history facilitates the early diagnosis of prostate carcinoma. Cancer (Phila.), 80: 1871-1874, 1997.